1. |
Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation, 2015, 132(15): 1435-1486.
|
2. |
Pant S, Patel NJ, Deshmukh A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol, 2015, 65(19): 2070-2076.
|
3. |
Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Assoc. World Clinical Drugs, 2016, 69(1): 69.
|
4. |
Chu VH, Park LP, Athan E, et al. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis clinical perspective. Circulation, 2015, 131(2): 131.
|
5. |
Kang DH. Timing of surgery in infective endocarditis. Heart, 2015, 101(22): 1786-1791.
|
6. |
Delahaye F. Is early surgery beneficial in infective endocarditis? A systematic review. Arch Cardiovasc Dis, 2011, 104(1): 35-44.
|
7. |
Muñoz P, Kestler M, De Alarcon A, et al. Current epidemiology and outcome of infective endocarditis: a multicenter, prospective, cohort study. Medicine (Baltimore), 2015, 94(43): e1816.
|
8. |
Mirabel M, Rattanavong S, Frichitthavong K, et al. Infective endocarditis in the Lao PDR: clinical characteristics and outcomes in a developing country. Int J Cardiol, 2015, 180: 270-273.
|
9. |
Delahaye F, M’Hammedi A, Guerpillon B, et al. Systematic search for present and potential portals of entry for infective endocarditis. J Am Coll Cardiol, 2016, 67(2): 151-158.
|
10. |
Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation, 2005, 111(23): e394-e434.
|
11. |
Morita K, Sasabuchi Y, Matsui H, et al. Outcomes after early or late timing of surgery for infective endocarditis with ischaemic stroke: a retrospective cohort study. Interact Cardiovasc Thorac Surg, 2015, 21(5): 604-609.
|
12. |
Said SM, Abdelsattar ZM, Schaff HV, et al. Outcomes of surgery for infective endocarditis: a single-centre experience of 801 patients. Eur J Cardiothorac Surg, 2017: doi: 10.1093/ejcts/ezx341.[Epub ahead of print.
|
13. |
Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med, 2012, 366(26): 2466-2473.
|
14. |
Delahaye F, Chu VH, Altclas J, et al. One-year outcome following biological or mechanical valve replacement for infective endocarditis. Int J Cardiol, 2015, 178: 117-123.
|
15. |
Gatti G, Benussi B, Gripshi F, et al. A risk factor analysis for in-hospital mortality after surgery for infective endocarditis and a proposal of a new predictive scoring system. Infection, 2017, 45(4): 413-423.
|